McGinnis Christopher A 4
4 · GoodRx Holdings, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
McGinnis Christopher A
See Remarks
Transactions
- Award
Restricted Stock Unit
2025-03-03+716,479→ 716,479 total→ Class A Common Stock (716,479 underlying) - Award
Stock Option (Right to Buy)
2025-03-03+1,096,937→ 1,096,937 totalExercise: $4.85Exp: 2035-03-03→ Class A Common Stock (1,096,937 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
- [F3]The option will vest and become exercisable as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.